SCHEMBL18156793

SCHEMBL18156793

Brc1cccc2c1-c1ccccc1C21c2ccccc2-c2c1ccc1c2-c2ccccc2C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.43
HTR2B P41595 1/20 0.36
MAOA P21397 1/20 0.33
POLB P06746 1/20 0.33
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA7 P43166 1/20 0.31
CA9 Q16790 1/20 0.31
DRD2 P14416 1/20 0.30
DRD4 P21917 1/20 0.30
DRD3 P35462 1/20 0.30
TRPA1 O75762 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18156791 0.86 PDK2 (0.41) PDK2HTR2BMAOAPOLBKDM4E
SCHEMBL18156789 0.83 PDK2 (0.41) PDK2HTR2BKDM4ENPC1ALDH1A1
SCHEMBL4195471 0.82 PDK2 (0.58) PDK2POLBKDM4EALDH1A1LMNA
SCHEMBL29603205 0.82 PDK2 (0.58) PDK2POLBKDM4EALDH1A1LMNA
SCHEMBL18156799 0.82 PDK2 (0.40) PDK2HTR2BMAOAKDM4ENPC1
SCHEMBL18156797 0.82 PDK2 (0.40) PDK2HTR2BMAOAKDM4ENPC1
SCHEMBL16810678 0.81 PDK2 (0.56) PDK2POLBKDM4EALDH1A1LMNA
SCHEMBL10053123 0.81 PDK2 (0.56) PDK2POLBKDM4EALDH1A1LMNA
SCHEMBL29484645 0.81 PDK2 (0.56) PDK2POLBKDM4EALDH1A1LMNA
SCHEMBL17816712 0.79 PDK2 (0.54) PDK2POLBKDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230126850-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2023-04-27 US disclosed
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 PDK2 264/4885HTR2B 2447/4885MAOA 3085/4885
US-20230126850-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 PDK2 264/4885HTR2B 2447/4885MAOA 3085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.